<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2022-28-3-253-259</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-2176</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Сочетание гипергомоцистеинемии и артериальной гипертензии у пациентов с атеросклерозом брахицефальных артерий: частота и клинико-лабораторные корреляты</article-title><trans-title-group xml:lang="en"><trans-title>Combination of hyperhomocysteinemia and hypertension in patients with atherosclerosis of brachiocephalic arteries: the frequency, clinical and laboratory correlates</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8342-3943</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рахматуллин</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Rakhmatullin</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рахматуллин Айрат Разифович — кандидат медицинских наук, доцент кафедры неврологии</p><p>Уфа</p></bio><bio xml:lang="en"><p>Ayrat R. Rakhmatullin, MD, PhD, Associate Professor, Department of Neurology</p><p>Ufa</p></bio><email xlink:type="simple">airatraxmatullin@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1001-2024</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутлубаев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutlubaev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кутлубаев Мансур Амирович — доктор медицинских наук, заведующий кафедрой неврологии</p><p>ул. Ленина, д. 3, Уфа, Россия, 450008</p></bio><bio xml:lang="en"><p>Mansur A. Kutlubaev, MD, PhD, DSc, Head, Department of Neurology</p><p>3, Lenin ul., Ufa, 450008</p></bio><email xlink:type="simple">mkmed@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Башкирский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>25</day><month>02</month><year>2022</year></pub-date><volume>28</volume><issue>3</issue><fpage>253</fpage><lpage>259</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рахматуллин А.Р., Кутлубаев М.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Рахматуллин А.Р., Кутлубаев М.А.</copyright-holder><copyright-holder xml:lang="en">Rakhmatullin A.R., Kutlubaev M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/2176">https://htn.almazovcentre.ru/jour/article/view/2176</self-uri><abstract><p>Сочетание артериальной гипертензии (АГ) и гипергомоцистеинемии выше 10 мкмоль/л нередко обозначается как гипертензия H-типа. Она значительно повышает риск развития сосудистых заболеваний, в том числе инсультов.</p><p>Цель исследования — оценить частоту и клинико-лабораторные корреляты сочетания гипергомоцистеинемии и АГ в выборке пациентов с атеросклерозом брахиоцефальных артерий (БЦА).</p><sec><title>Материалы и методы</title><p>Материалы и методы. Набирались амбулаторные пациенты, у которых, по данным скринингового ультразвукового дуплексного сканирования БЦА, выявлялись признаки атеросклероза. Регистрировались анамнестические данные пациентов. Исследовались клинический, биохимический (липидные фракции, креатинин) анализы крови, клинический анализ мочи, дополнительно — уровень гомоцистеина, C-реактивного белка.</p></sec><sec><title>Результаты</title><p>Результаты. Проанализированы данные 93 пациентов. Частота сочетания гипергомоцистеинемии и АГ среди пациентов с атеросклерозом БЦА составила 95%. Уровень гомоцистеина был выше у мужчин, чем у женщин (p = 0,001). Корреляционный анализ выявил прямую слабую связь между уровнем гомоцистеина и количеством лейкоцитов, эритроцитов, моноцитов, уровнем креатинина в крови и микроальбумина в моче (p &lt; 0,05). Мужской пол и уровень микроальбумина в моче были независимыми предикторами повышения уровня гомоцистеина у данной категории пациентов по данным линейного регрессионного анализа.</p></sec><sec><title>Заключение</title><p>Заключение. Сочетание гипергомоцистеинемии и АГ широко распространено среди пациентов с атеросклерозом БЦА. При планировании мероприятий по профилактике ишемических инсультов у пациентов с АГ и атеросклерозом БЦА целесообразно проводить исследование уровня гомоцистеина с последующим решением вопроса о назначении витаминов группы В.</p></sec></abstract><trans-abstract xml:lang="en"><p>Combination of hypertension (HTN) and hyperhomocysteinemia &gt; 10 mсmol/l is frequently called H-type hypertension. It is associated with an increased risk of vascular events including stroke.</p><sec><title>Objective</title><p>Objective. To estimate the frequency and clinical and laboratory correlates of combination of hyperhomocysteinemia and HTN in a cohort of patients with atherosclerosis of brachiocephalic arteries (BCA).</p></sec><sec><title>Design and methods</title><p>Design and methods. We recruited out-patients with confirmed atherosclerosis of BCA based on the ultrasound duplex scans. History were registered. Complete blood count, biochemical analysis (lipids, creatinine, homocysteine and C-reactive protein) and urine analysis were performed.</p></sec><sec><title>Results</title><p>Results. Data from 93 patients were analyzed. The frequency of combination of hyperhomocysteinemia and HTN among patients with atherosclerosis of BCA was 95%. The level of homocysteine was higher in males than in females (p = 0,001). Correlation analysis showed a direct weak association between the level of homocysteinemia and the number of white blood cells, red blood cells, monocytes, level of creatinine in the blood and microalbuminuria (p &lt; 0,05). Linear regression analysis showed that male gender along with microalbuminuria were independent predictors of the homocysteine level in these patients.</p></sec><sec><title>Conclusions</title><p>Conclusions. A combination of hyperhomocysteinemia and HTN is common among patients with the atherosclerosis of BCA. Stroke prevention measures in patients with HTN and atherosclerosis of BCA should include assessment of homocysteine level and prescription of B vitamins if needed.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гомоцистеин</kwd><kwd>артериальная гипертензия</kwd><kwd>инсульт</kwd><kwd>атеросклероз</kwd><kwd>профилактика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>homocysteine</kwd><kwd>hypertension</kwd><kwd>stroke</kwd><kwd>atherosclerosis</kwd><kwd>prevention</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W, Ji P, Wang Y, Guo H, Bian R, Xu J et al. Prevalence of hyperhomocysteinemia and its associated factors in patients with primary hypertension in Chinese urban communities: A crosssectional study from Nanjing. Clin Exp Hypertens. 2018;40(5):495– 500. doi:10.1080/10641963.2017.1403621</mixed-citation><mixed-citation xml:lang="en">Wang W, Ji P, Wang Y, Guo H, Bian R, Xu J et al. Prevalence of hyperhomocysteinemia and its associated factors in patients with primary hypertension in Chinese urban communities: A crosssectional study from Nanjing. Clin Exp Hypertens. 2018;40(5):495– 500. doi:10.1080/10641963.2017.1403621</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Родионов Р. Н, Лентц С.Р. Современные представления о гипергомоцистеинемии как факторе риска сердечно-сосудистых заболеваний. Артериальная гипертензия. 2008;14(2):110– 15. doi:10.18705/1607-419X‑2008-14-2-110-115</mixed-citation><mixed-citation xml:lang="en">Rodionov RN, Lentz SR. Hyperhomocystcinemia as a cardiovascular risk factor. Current concepts. Arterial’naya Gipertenziya = Arterial Hypertension. 2008;14(2):110–115. doi:10.18705/1607-419X‑2008-14-2-110-115. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Li T, Liu X, Diao S, Kong Y, Duan X, Yang S et al. H-type hypertension is a risk factor for cerebral small-vessel disease. Biomed Res Int. 2020;2020:6498903. doi: 10.1155/2020/6498903</mixed-citation><mixed-citation xml:lang="en">Li T, Liu X, Diao S, Kong Y, Duan X, Yang S et al. H-type hypertension is a risk factor for cerebral small-vessel disease. Biomed Res Int. 2020;2020:6498903. doi: 10.1155/2020/6498903</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mechtouff L, Rascle L, Crespy V, Canet-Soulas E, Nighoghossian N, Millon A. A narrative review of the pathophysiology of ischemic stroke in carotid plaques: a distinction versus a compromise between hemodynamic and embolic mechanism. Ann Transl Med. 2021;9(14):1208. doi:10.21037/atm‑20-7490</mixed-citation><mixed-citation xml:lang="en">Mechtouff L, Rascle L, Crespy V, Canet-Soulas E, Nighoghossian N, Millon A. A narrative review of the pathophysiology of ischemic stroke in carotid plaques: a distinction versus a compromise between hemodynamic and embolic mechanism. Ann Transl Med. 2021;9(14):1208. doi:10.21037/atm‑20-7490</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Liu Y, Wang A, Wang D, Jiang R, Jia J et al. Association between H-type hypertension and asymptomatic extracranial artery stenosis. Sci Rep. 2018;8(1):1328. doi:10.1038/s41598-018-19740-0</mixed-citation><mixed-citation xml:lang="en">Zhang J, Liu Y, Wang A, Wang D, Jiang R, Jia J et al. Association between H-type hypertension and asymptomatic extracranial artery stenosis. Sci Rep. 2018;8(1):1328. doi:10.1038/s41598-018-19740-0</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Никитин Ю. М., Труханов А. И. Ультразвуковая допплеровская диагностика сосудистых заболеваний. М.: ВИДАР, 1998. 432 с.</mixed-citation><mixed-citation xml:lang="en">Nikitin YuM, Trukhanov AI. Ultrasound Doppler diagnosis of vascular diseases. M.: VIDAR, 1998. 432 p. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Ощепкова Е. В, Жернакова Ю.В. Рекомендации по диагностике и лечению АГ. Кардиологический вестник. 2015;3:5–30.</mixed-citation><mixed-citation xml:lang="en">Chazova IE, Oshhepkova EV, Zhernakova YuV. Guidelines for the management of arterial hypertension. Kardiologicheskij Vestnik = Cardiology Bulletin. 2015;3:5–30. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Q, Lu Y, Deng Y, Xu J, Zhang X. Homocysteine level is positively and independently associated with serum creatinine and urea nitrogen levels in old male patients with hypertension. Sci Rep. 2020;10(1):18050. doi:10.1038/s41598-020-75073-x</mixed-citation><mixed-citation xml:lang="en">Yang Q, Lu Y, Deng Y, Xu J, Zhang X. Homocysteine level is positively and independently associated with serum creatinine and urea nitrogen levels in old male patients with hypertension. Sci Rep. 2020;10(1):18050. doi:10.1038/s41598-020-75073-x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lau WL, Huisa BN, Fisher M. The Cerebrovascular-chronic kidney disease connection: perspectives and mechanisms. Transl Stroke Res. 2017;8(1):67–76. doi:10.1007/s12975-016-0499-x</mixed-citation><mixed-citation xml:lang="en">Lau WL, Huisa BN, Fisher M. The Cerebrovascular-chronic kidney disease connection: perspectives and mechanisms. Transl Stroke Res. 2017;8(1):67–76. doi:10.1007/s12975-016-0499-x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Okura T, Miyoshi K, Irita J, Enomoto D, Nagao T, Kukida M et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep. 2014;4:5663. doi:10.1038/srep05663</mixed-citation><mixed-citation xml:lang="en">Okura T, Miyoshi K, Irita J, Enomoto D, Nagao T, Kukida M et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep. 2014;4:5663. doi:10.1038/srep05663</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Baszczuk A, Musialik K, Kopczyński J, Thielemann A, Kopczyński Z, Kęsy L et al. Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension. Adv Med Sci. 2014;59(1):68–73. doi:10.1016/j.advms.2013.08.001</mixed-citation><mixed-citation xml:lang="en">Baszczuk A, Musialik K, Kopczyński J, Thielemann A, Kopczyński Z, Kęsy L et al. Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension. Adv Med Sci. 2014;59(1):68–73. doi:10.1016/j.advms.2013.08.001</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C, Sun X, Lin H, Zheng R, Ruan L, Sun Z et al. Association between hyperhomocysteinemia and metabolic syndrome with early carotid artery atherosclerosis: a cross-sectional study in middle-aged Chinese population. Nutrition. 2018;53:115– 119. doi:10.1016/j.nut.2018.02.014</mixed-citation><mixed-citation xml:lang="en">Liu C, Sun X, Lin H, Zheng R, Ruan L, Sun Z et al. Association between hyperhomocysteinemia and metabolic syndrome with early carotid artery atherosclerosis: a cross-sectional study in middle-aged Chinese population. Nutrition. 2018;53:115– 119. doi:10.1016/j.nut.2018.02.014</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Elias MF, Brown CJ. New evidence for homocysteine lowering for management of treatment-resistant hypertension. Am J Hypertens. 2021: hpab194. doi:10.1093/ajh/hpab194. Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Elias MF, Brown CJ. New evidence for homocysteine lowering for management of treatment-resistant hypertension. Am J Hypertens. 2021: hpab194. doi:10.1093/ajh/hpab194. Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Spence JD, Yi Q, Hankey GJ. B vitamins in stroke prevention: time to reconsider. Lancet Neurol. 2017;16(9):750–760. doi:10.1016/S1474-4422(17)30180-1</mixed-citation><mixed-citation xml:lang="en">Spence JD, Yi Q, Hankey GJ. B vitamins in stroke prevention: time to reconsider. Lancet Neurol. 2017;16(9):750–760. doi:10.1016/S1474-4422(17)30180-1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
